Effects of ACE Inhibitors or ↓-Blockers in Patients Treated with the Fixed-Dose Combination of Isosorbide Dinitrate/Hydralazine in the African-American Heart Failure Trial

被引：0
|
作者：
Jalal K. Ghali
S. William Tam
Keith C. Ferdinand
JoAnn Lindenfeld
Michael L. Sabolinski
Anne L. Taylor
Manuel Worcel
Charles L. Curry
Jay N. Cohn
机构：
[1] University Health Center,Cardiovascular Division, Department of Medicine
[2] 2E,undefined
[3] Wayne State University,undefined
[4] NitroMed,undefined
[5] Inc.,undefined
[6] Black Cardiologist Association,undefined
[7] University Hospital,undefined
[8] University of Colorado,undefined
[9] University of Minnesota,undefined
[10] Howard University,undefined
[11] College of Medicine,undefined
来源：
American Journal of Cardiovascular Drugs | 2007年 / 7卷
关键词：
Heart Failure; Nitric Oxide; Enalapril; Systolic Heart Failure; Heart Failure Hospitalization;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：373 / 380
页数：7
相关论文
共 50 条
  • [21] Use of Isosorbide Dinitrate and Hydralazine in African-Americans With Heart Failure 9 Years After the African-American Heart Failure Trial
    Ferdinand, Keith Copelin
    Elkayam, Uri
    Mancini, Donna
    Ofili, Elizabeth
    Pina, Ileana
    Anand, Inder
    Feldman, Arthur Michael
    McNamara, Dennis
    Leggett, Christopher
    AMERICAN JOURNAL OF CARDIOLOGY, 2014, 114 (01): : 151 - 159
  • [22] BNP predicts event-free survival in African American patients with moderate to severe heart failure but does not identify responders to fixed-dose combination of isosorbide dinitrate/hydralazine
    Rame, J. Eduardo
    De Marco, Teresa
    McGlothlin, Dana
    Hu, Xinge
    Dries, Daniel L.
    Worcel, Manuel
    Tam, S. William
    Cohn, Jay N.
    CIRCULATION, 2007, 116 (16) : 650 - 651
  • [23] Fixed-dose combination of isosorbide dinitrate and hydralazine inhibits left ventricular remodeling in well-treated severe heart failure in African-Americans: A-HeFT
    Cohn, JN
    Anand, I
    Taylor, A
    Tan, SW
    CIRCULATION, 2005, 112 (17) : U704 - U704
  • [24] Fixed-dose combination of isosorbide dinitrate and hydralazine inhibits left ventricular remodeling in well-treated severe heart failure in African-Americans: A-HeFT
    Cohn, JN
    Anand, I
    Taylor, A
    JOURNAL OF CARDIAC FAILURE, 2005, 11 (09) : 720 - 720
  • [25] Lack of bioequivalence between different formulations of isosorbide dinitrate and hydralazine and the fixed-dose combination of isosorbide dinitrate/hydralazine - The V-HeFT paradox
    Tam, S. William
    Sabolinski, Michael L.
    Worcel, Manuel
    Packer, Milton
    Cohn, Jay N.
    CLINICAL PHARMACOKINETICS, 2007, 46 (10) : 885 - 895
  • [26] GNB3 TT genotype predicts enhanced benefit of fixed-dose combination of isosorbide dinitrate and hydralazine in African Americans with heart failure: Results of the A-HeFT trial
    McNamara, Dennis M.
    Tam, S. William
    Sabolinski, Michael L.
    Tobelmann, Page
    Hanley-Yanez, Karen
    Janosko, Karen M.
    Worcel, Manuel
    JOURNAL OF CARDIAC FAILURE, 2006, 12 (06) : S71 - S71
  • [27] Isosorbide dinitrate-hydralazine combination therapy in African Americans with heart failure
    Echols, Melvin R.
    Yancy, Clyde W.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2006, 2 (04) : 423 - 431
  • [28] Effects of Fixed-Dose Isosorbide Dinitrate/Hydralazine on Diastolic Function and Exercise Capacity in Hypertension-Induced Diastolic Heart Failure
    Wilson, Richard M.
    De Silva, Deepa S.
    Sato, Kaori
    Izumiya, Yasuhiro
    Sam, Flora
    HYPERTENSION, 2009, 54 (03) : 583 - U265
  • [29] Use of Isosorbide Dinitrate/Hydralazine Combination in Pediatric Patients with Heart Failure
    Musa, N.
    Law, Y.
    Richardson, N.
    Albers, E.
    Kemna, M.
    Friedland-Little, J.
    Hong, B.
    Mazor, R.
    JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2018, 37 (04): : S390 - S390
  • [30] USE OF HYDRALAZINE/ISOSORBIDE DINITRATE COMBINATION IN AFRICAN-AMERICAN AND OTHER RACE/ETHNIC GROUP PATIENTS WITH HEART FAILURE AND REDUCED LEFT VENTRICULAR EJECTION FRACTION
    Golwala, Harsh
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2013, 61 (10) : E685 - E685
12345